Venta ZELTIA

Hemos procedido a deshacernos del valor, al acercarnos a los objetivos de 2,95 Euros.

Aunque el Ibex se mantiene fuerte, pensamos que la corrección que se aproxima en las Bolsas Americanas, pueden hacer retroceder al Mercado Español.

Histórico del valor:

Fecha de compra: 12 de diciembre de 2013

Precio de compra: 2,32 Euros

Fecha de venta: 8 de abril de 2014

Precio de venta: 2,90 Euros

Rentabilidad: 25 %

Compra ZELTIA

Compramos Zeltia, aprovechando recortes a su media de 30 semanas.

Mercado Continuo. España.
Compra 12/12/2013
Precio: 2,32 Euros
Soporte: 2,20 Euros

Zeltia SA is a Spain-based holding company primarily engaged, through its subsidiaries, in the chemical and biopharmaceutical sectors. In the biopharmaceutical area the Company’s main subsidiaries are: PharmaMar SA, a biopharmaceutical company engaged in the research, development, production and marketing of marine-based drugs for application in oncology; Noscira SA, whose main activities comprise the research and development of drugs for diseases of the nervous system; Genomica SAU, which specializes in molecular diagnostics; and Sylentis SAU, focused on the developing of new therapeutic approaches based on gene silencing techniques. In the chemical sector the Company operates through Zelnova SA, which produces and markets cleaning products for household, industry and gastronomic establishments; and Xylazel SA and Copyr SpA, which are producers of paints, aerosols, varnishes, products for the ecological agriculture, as well as wood and metal protectors for the industrial sector.

Más información.